Founder & CEO attended 30th BIO Europe conference
Pharmahungary Group Founder & CEO will attend the 30th BIO Europe conference in Stockholm, Sweden between November 4-6. During the conference Prof. Ferdinandy will introduce the innovative in-house R&D projects of Pharmahungary Group that are open for investment, out-licensing, and co-development partnerships as well as our miRNAI discovery and development service platform:
1. protectomiRs: proprietary oligonucleotides for treatment of cardiovascular diseases
2. miRNAtarget: development of AI-driven drug discovery tools for oligonucleotide discovery
3. miRNAI discovery and development service platform: bioinformatics and pharmacology validation tools for discovery and development of oligonucleotide-type therapeutics
Contact us for more information on our novel in-house R&D projects and innovative preclinical R&D services today: businessdevelopment@pharmahungary.com.